PDEA Drug-Free Workplace Policy Guidelines

The Philippine Drug Enforcement Agency (PDEA) is mandated to lead in the anti-drug campaign by institutionalizing a drug-free workplace.
Guidelines require the creation of a Drug Abuse Policy and a Drug-Free Workplace Committee to implement these policies.

PDEA must set an example in implementing RA 9165 by ensuring a safe work environment.
Strong condemnation of illegal drug use and related offenses among personnel.
The policy aims to prevent any incidence of drug abuse in the agency.

Section 36(e), Article III of RA 9165 mandates officers and members of law enforcement agencies to be drug-free.
Article V, RA 9165 promotes national drug-free workplace programs involving various sectors.
DDB Board Regulation No. 2 (2004) requires agencies to adopt drug abuse policies.
CSC Resolution No. 101359 (2010) reiterates drug-free workplace guidelines in government agencies.

To institutionalize a Drug-Free Workplace Program within the PDEA for all personnel.

"Administer," "Dangerous Drugs," "Donor," "Drug Test Certificate," "Mandatory Drug Test," among others.
Includes definitions of the different types of drug tests: screening, confirmatory, challenge test.
Clarifies unlawful acts like sale, use, and possession of dangerous drugs.

Chaired by the Deputy Director General for Administration with membership from key PDEA services.
Responsibilities include overseeing policy implementation, education, values formation, and monitoring the Drug-Free Workplace Program.

Installation of signages declaring a drug-free workplace.
Mandatory drug testing for pre-employment and promotion.
Annual surprise drug testing of all personnel.
Strict adherence to DDB regulations in testing procedures.
Confidential handling of laboratory reports.
Positive drug tests constitute prima facie evidence of drug use and grave misconduct.
Refusal to undergo mandatory tests treated as positive results.
Inclusion of drug-free workplace modules in PDEA training.
Promotion of healthy lifestyle and continuous policy evaluation.

Detailed requirements for specimen collection: sample volume, bottles, secure collection site criteria.
Proper documentation via Consent Forms, Custody and Control Forms, and Receiving Logbooks.
Screening testing to identify presumptive positives followed by confirmatory testing.
Procedures for informing donors and handling medical declarations for legal drug use.
Timely notification of test results to involved parties.

Confirmatory tests must be conducted by authorized laboratories with advanced analytical equipment (GCMS).
Donor has 15 days to request a re-examination by an authorized laboratory at own expense.
Chain of custody and handling procedures to ensure specimen integrity during challenges.
Final determination based on challenge test results.

After the challenge period or upon receipt of challenge test results, a Show Cause Order is issued.
Preliminary investigation to assess prima facie case for Grave Misconduct.
Formal Charge issuance and opportunity for respondent's answer.
Conduct of formal investigation or issuance of a decision based on evidence.
Disciplining authority's decision to be issued within 30 days of investigation report.

Assessment Committee through Plans and Operations Service monitors policy promotion and implementation.
Integration of policy in PDEA’s plans and programs, ensuring compliance by all services.

The memorandum circular takes effect 15 days after publication in the Office of National Administrative Register.